Dierckx RAJO - Search Results

1

Avenues to molecular imaging of dying cells: Focus on cancer.

Rybczynska AA, Boersma HH, de Jong S, Gietema JA, Noordzij W, Dierckx RAJO, Elsinga PH, van Waarde A. Rybczynska AA, et al. Among authors: dierckx rajo. Med Res Rev. 2018 Sep;38(6):1713-1768. doi: 10.1002/med.21495. Epub 2018 Mar 12. Med Res Rev. 2018. PMID: 29528513 Free PMC article. Review.

2

Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation.

van Waarde A, Jager PL, Ishiwata K, Dierckx RA, Elsinga PH. van Waarde A, et al. J Nucl Med. 2006 Jan;47(1):150-4. J Nucl Med. 2006. PMID: 16391199 Free article.

3

Early response of sigma-receptor ligands and metabolic PET tracers to 3 forms of chemotherapy: an in vitro study in glioma cells.

van Waarde A, Been LB, Ishiwata K, Dierckx RA, Elsinga PH. van Waarde A, et al. J Nucl Med. 2006 Sep;47(9):1538-45. J Nucl Med. 2006. PMID: 16954564 Free article.

4

Rapid reduction of sigma1-receptor binding and 18F-FDG uptake in rat gliomas after in vivo treatment with doxorubicin.

van Waarde A, Shiba K, de Jong JR, Ishiwata K, Dierckx RA, Elsinga PH. van Waarde A, et al. J Nucl Med. 2007 Aug;48(8):1320-6. doi: 10.2967/jnumed.107.042085. Epub 2007 Jul 13. J Nucl Med. 2007. PMID: 17631546 Free article.

5

Synthesis and preliminary evaluation of (S)-[11C]-exaprolol, a novel beta-adrenoceptor ligand for PET.

van Waarde A, Doorduin J, de Jong JR, Dierckx RA, Elsinga PH. van Waarde A, et al. Neurochem Int. 2008 Mar-Apr;52(4-5):729-33. doi: 10.1016/j.neuint.2007.09.009. Epub 2007 Sep 19. Neurochem Int. 2008. PMID: 17961850

6

Evaluation of [(11)C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation.

de Vries EF, Doorduin J, Dierckx RA, van Waarde A. de Vries EF, et al. Nucl Med Biol. 2008 Jan;35(1):35-42. doi: 10.1016/j.nucmedbio.2007.07.015. Epub 2007 Sep 19. Nucl Med Biol. 2008. PMID: 18158941

7

Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study.

de Vries EF, Doorduin J, Vellinga NA, van Waarde A, Dierckx RA, Klein HC. de Vries EF, et al. Nucl Med Biol. 2008 May;35(4):459-66. doi: 10.1016/j.nucmedbio.2008.01.005. Epub 2008 Apr 3. Nucl Med Biol. 2008. PMID: 18482683

8

Manipulation of [11C]-5-hydroxytryptophan and 6-[18F]fluoro-3,4-dihydroxy-L-phenylalanine accumulation in neuroendocrine tumor cells.

Neels OC, Koopmans KP, Jager PL, Vercauteren L, van Waarde A, Doorduin J, Timmer-Bosscha H, Brouwers AH, de Vries EG, Dierckx RA, Kema IP, Elsinga PH. Neels OC, et al. Cancer Res. 2008 Sep 1;68(17):7183-90. doi: 10.1158/0008-5472.CAN-08-0095. Cancer Res. 2008. PMID: 18757434

9

Cytotoxicity of sigma-receptor ligands is associated with major changes of cellular metabolism and complete occupancy of the sigma-2 subpopulation.

Rybczynska AA, Dierckx RA, Ishiwata K, Elsinga PH, van Waarde A. Rybczynska AA, et al. J Nucl Med. 2008 Dec;49(12):2049-56. doi: 10.2967/jnumed.108.053876. Epub 2008 Nov 7. J Nucl Med. 2008. PMID: 18997057 Free article.

10

Growth factor/peptide receptor imaging for the development of targeted therapy in oncology.

Van de Wiele C, Boersma H, Dierckx RA, De Spiegeleer B, Van Waarde A, Elsinga PH. Van de Wiele C, et al. Curr Pharm Des. 2008;14(31):3340-7. doi: 10.2174/138161208786549434. Curr Pharm Des. 2008. PMID: 19075711 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

545 results

Search Page

Filters